This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) rallied 1.30% to $553.58 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index rising 1.08% to 7,432.97 and the Dow Jones Industrial Average rising 1.31% to 50,009.35.
This was the stock's third consecutive day of gains.
IDEXX Laboratories Inc. closed 28.10% below its 52-week high of $769.98, which the company reached on November 26th.
The stock outperformed some of its competitors Wednesday, as Johnson &amp; Johnson (JNJ) fell 0.30% to $229.32, Medtronic PLC (MDT) fell 0.55% to $78.15, and Boston Scientific Corp. (BSX) fell 0.25% to $56.67.
Trading volume (614,663) eclipsed its 50-day average volume of 566,050.
Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-20-26 1652ET

IDXX

LABU

IDEXX Laboratories Inc. (IDXX) shares rose 1.30% to $553.58 on a strong trading day, outperforming competitors like Johnson & Johnson and Medtronic. This marks the third consecutive day of gains for IDEXX, although it remains 28.10% below its 52-week high of $769.98. The S&P 500 and Dow Jones also saw increases of 1.08% and 1.31%, respectively.

MarketWatch Automated

IDEXX Labs

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

SPDR S&P Health Equip

VanEck Biotech ETF

iShares Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

Health Care Select Sector SPDR

iShares US Medical Devices

Invesco Biotechnology & Genome ETF

iShares US Healthcare Providers

SPDR S&P Biotech

ALPS Medical Breakthrough

Ark Genomic Revolution ETF

First Trust NYSE Arca Biotech Index Fd

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Medtronic

Boston Scientific

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day